According to current clinical practice guidelines for pharmacological management of obesity published in 2015 by The Endocrine Society, if a patients weight is not responsive to lifestyle intervention, weight loss pharmacotherapy can be offered for a BMI 27kg/m 2 when an obesity-related comorbidity is present, or when the BMI is 30kg/m 2 (1)
"For example, deciding not to weigh oneself, or not to talk about dieting, weight loss, et cetera when you're sitting around talking to your colleagues
The reusable pen enables patients to replace only the medication cartridge rather than purchasing a new disposable pen each time, thereby reducing cost and helping better patient adherence to treatment, explains Vikas Gupta, chief executive officer, Alkem
But reduced appetite without nutritional strategy leads to muscle loss, nutrient deficiency, and metabolic adaptation